Recently, under the guidance of the State Administration for Market Regulation, the working group of China Food and Drug Corporation Quality and Safety Promotion Association (hereinafter referred to as the "Promotion Association") conducted an investigation on the practice of "six guarantees" in food and drug manufacturers in Henan Province, which focused on investgating the party building guidance, quality and safety assurance and staff skills training in food and drug enterprises, understanding the experience and achievements and existing problems of enterprises in drug research and development, clinical research, registration and application, production quality management and talent support. The Promotion Association plays a bridge and link role in reflecting the demands of enterprises to the government subdivision, helping enterprises solve the problems in management, and facilitating their development.
 

On August 26, Zhu Rui, the Party branch secretary of Promotion Association, Chen Jicheng, vice President, Xie Jiuzhong and He Tao, vice executive secretary, visited Lingkong biomedical park and Beijing Leadingpharm and Zhengzhou Shenlanhai, accompanied by Zhang Mingwan, the director of food and drug publicity and education center in Henan Province, Zhou Guilan, the researcher of drug registration office, Zhang Hongtai, the director of the office, Lu Yuan and Wu kunpeng, the chief of the drug production department.

At the meeting, the secretary Zhu Rui detailedly introduced the basic situation of the "six guarantees" investigation and the significance of the investigation to everyone. As the leader of CRO industry, Beijing Leadingpharm has been doing practical work and seeking development all the time, which can truly reflect the actual situation of the enterprise, and its pragmatic work style is worthy of affirmation and further development.

Xie Jiuzhong, the vice executive secretary, attaches great importance to the party building in enterprises. He proposes to use the party's high-level ideology and theory to guide the enterprise, and has made a profound communication with the participants about the development of enterprise party building work.

Zhang Mingwan, the director of food and drug publicity and education center in Henan Province, and Zhou Guilan, the director of the drug registration office, made speeches, respectively, proposing that the Provincial Bureau should deeply understand the actual situation of enterprises, effectively solve the needs of enterprises in the actual work process, and provide policy support and guidance for the innovation and development of enterprises.

Subsequently, Ma Bing, the assistant general manager of Zhengzhou ChuangTai biotechnology Service Co., Ltd., Zhang Lizhuang, the deputy general manager of Henan Taloph Pharmaceutical Co., Ltd., and Zhao Deqian, the general manager of Beijing Leadingpharm liquid preparation division, reported the overall situation of Lingkong biomedical park, Henan Taloph pharmaceutical industry and Beijing Leadingpharm, respectively. The leaders attended the meeting highly recognized the innovative advantages and industry leading role of the Beijing Leadingpharm CXO mode, and made a further discussion on CXO mode.

At the end of the discussion, Zhu Rui, the Party branch secretary of Promotion Association, stressed in his concluding speech that through deep integration and specialized division of labor, the Leadingpharm CXO system effectively link up technological research and development, clinical research and production, and clinical application, which can effectively improve drug R & D innovation capacity and industrial transformation efficiency of our country. These successful experiences are important guarantees for the implementation of the "six guarantees". It is hoped that through this activity, the two sides will establish in-depth communications to promote the innovation vitality and high-quality development of China's pharmaceutical and health industry.

Pose for a group photo of leaders of Promotion Association, Provincial Bureau, biomedical Park, Taloph and Leadingpharm • Shenlanhai.
 

After the meeting, accompanied by Ma Bing, the assistant general manager of Zhengzhou ChuangTai biotechnology Service Co., Ltd., Zhang Lizhuang, the deputy general manager of Henan Taloph Pharmaceutical Co., Ltd., Zhao Deqian, the general manager of Beijing Leadingpharm liquid preparation division,, and Yu Yunping, the leader of Zhengzhou shenlanhai, the leaders visited the biomacromolecule platform together.
 

Introduction of Leadingpharm CXO system

Beijing Leadingpharm Medicine Technology Development Co., Ltd. relies on the existing technology and management team, integrates Zhengzhou Linkong biomedical park platform, fully invests, constructs and operates six technical service platforms in line with international standards included “new drug screening and detection platform, drug evaluation platform (animal room), macromolecule pilot and large-scale production service platform, small molecule CMC research and production platform, cell technology service platform, clinical CRO platform” and opens up the upstream and downstream industries of pharmaceutical R & D. Beijing Leadingpharm CXO system multi-dimensional and all-round enabling innovation enterprises to break through the bottleneck and promote the rapid development of the pharmaceutical industry.